drugset / Trial / NCT00721825

Study of NeuroAid In Enhancing Recovery After Stroke

NCT00721825 ↗

Phase 2 Completed 40 enrolled Moleac Pte Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

TIERS is a phase II to generate detailed preliminary data on the efficacy of NeuroAid in post-stroke recovery, and to assess the utility of the rehabilitation outcome measure instruments used.

Timeline

Start
2008-01
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator NeuroAiD Traditional medicine (herbal / TCM) 4 unknown —

Indications